Viewing Study NCT01708161

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:11 PM
Ignite Modification Date: 2025-12-27 @ 10:39 PM
Study NCT ID: NCT01708161
Status: TERMINATED
Last Update Posted: 2018-09-13
First Post: 2012-09-19
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None PIK3CA Mutated Advanced Solid Tumors View
None PIK3CA Amplified Advanced Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PIK3CA mutation View
None advanced solid tumor View
None breast cancer View
None ovarian cancer View
None cancers with a mass View
None bulky tumor View
None nodule View
None lump View
None advanced cancer View
None advanced solid malignancies View